Webinar Date/Time: Thursday June 29, 2023 at 2pm EDT | 1pm CDT | 11am PDT
In this webcast, learn the importance of analytical characterization of material. Discover how it helps maintain quality attributes within specified limits, identifies potential CMC problems, and addresses them in early manufacturing development.
Register Free: https://www.pharmtech.com/pt_w/label-free
Event Overview:
In this webinar learn about a label-free single cell analysis capability where the use of antibodies or genetic labeling is not required. This new type of laser physics approach offers benefits for analysis compared with conventional label-based flow cytometry methods.
Key Learning Objectives
Who Should Attend
Speaker
Sean Hart, PhD
Chief Scientific Officer & CEO
LumaCyte
Dr. Hart has 50+ peer reviewed journal articles, numerous invited and contributed presentations, 4 patents issued / 4 pending, and has managed large research teams with multi-million dollar budgets. Dr. Hart has extensive experience in a diverse range of research areas including spectroscopy, laser trapping and separation, optical engineering, chromatography, chemical and biochemical separation, statistical data analysis/calibration and artificial intelligence. He received his PhD in Chemistry at Tufts University in 1998. He has significant experience with taking new technology from the lab bench to prototype and field applications.
Register Free: https://www.pharmtech.com/pt_w/label-free
Sponsors
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Legal and Regulatory Perspectives on 3D Printing: Drug Compounding Applications
December 10th 2024This paper explores the legal and regulatory framework around 3D drug printing, particularly for personalized medicine, considering regulatory compliance, business concerns, and intellectual property rights.